Zidovudine oral sol.10mg/ml/BOT-100ml
NOTE: The description below is for a standard product. It is notspecific to patent status and pricing policies that may apply at countrylevel. This information is available on request from Supply Division:Contact: supply@unicef.org
General Description:
Zidovudine oral solution 10mg/ml, bottle 100ml with oral dispensingsyringe
Technical Specifications:
Each 1 ml oral solution contains Zidovudine 10mg. Pack comes with oraldispensing syringe
Therapeutic class:
Zidovudine (AZT) is a Nucleoside Reverse Transcriptase Inhibitor (NRTI).
Standard shelf life:
36 months
Other available formulations:
The product may also be available in other formulations, pack sizes, orin combinations with other ARVs.
Guidelines for use:
For more details, please click the links listed below:
and
WHO EssentialMedicines Library
or your regional national guidelines
For details about paediatric dosage schemes, please click the linkslisted below:
WHO Generic tool for assessing paediatric ARV dosing
Indications:
Management of HIV infection in adults and children in combination withat least two other antiretroviral drugs. By mouth (oral), PO
PMTCT: In combination with other drugs for prevention of mother-to childHIV transmission.
Packaging and storage:
Do not store above 30ºC (86ºF).
Store in tightly closed original container
Keep out of reach and sight of children.
Dispensing instructions:
Dispense in original container. Do not repack
Regulatory Status:
For latest updates, please click the links listed below: